Design, Synthesis, and Hypoxia‐Inducible Factor‐1α Inhibitory Activity Evaluation of Panaxadiol Derivatives Containing a Thiazole Moiety
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202401542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Xin-Yu Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Yanbian University College of Pharmacy, Yanji, 133000, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Thiazoles, Ginsenosides, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Higher Education Discipline Innovation Project, Changbai Mountain Natural Medicine.
Abstract (Originalsprache)
The hypoxia‐inducible factor‐1α (HIF‐1α) pathway has been implicated in tumor angiogenesis, growth, and metastasis. Therefore, the inhibition of this pathway is an important therapeutic target for cancer. Thiazole derivatives have been reported to have diverse biological activities, especially in terms of anti‐tumor. Consequently, we hypothesized that the introduction of a thiazole functional group in PD was likely to improve the biological potency. Here, three series of PD derivatives containing a thiazole moiety were synthesized, including (a) sulfonyl‐containing thiazole derivatives ( 5 a – l ), (b) urea‐containing thiazole derivatives ( 7 a – i ), and (c) thiourea‐containing thiazole derivatives ( 9 a – i ), and evaluated for HIF‐1α inhibitory activity using a Hep3B cell‐based luciferase reporter assay. The results showed that about 1/3 of the target compounds showed moderate or strong HIF‐1α inhibitory activity, among which compounds 5 d and 7 b showed the strongest inhibitory activity with IC 50 values of 17.37 and 6.42 μM, respectively, and did not show any significant cytotoxicity. Western blot assay results indicated that these two compounds exhibited more potent inhibition, compared with panaxadiol, of the expression of HIF‐1α protein in Hep3B cells at a concentration of 50 μM. Molecular docking experiments were also performed to investigate the structure–activity relationship. Compounds 5 d and 7 b can be used as leads for further study and development of novel antitumor drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, Yanbian University College of Pharmacy, Yanji, 133000, China.
ORCID-Profile: Hu-Ri Piao
Förderung
- Higher Education Discipline Innovation Project
- Changbai Mountain Natural Medicine
Zitieren
APA
Ma, X. Y., Li, M. Y., Jin, K. H., Han, Z. Y., Gao, Y. L., Jin, X. J., Zhao, Y. Q., & Piao, H. R. (2024). Design, Synthesis, and Hypoxia‐Inducible Factor‐1α Inhibitory Activity Evaluation of Panaxadiol Derivatives Containing a Thiazole Moiety. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401542
Vancouver
Ma XY, Li MY, Jin KH, Han ZY, Gao YL, Jin XJ, et al. Design, Synthesis, and Hypoxia‐Inducible Factor‐1α Inhibitory Activity Evaluation of Panaxadiol Derivatives Containing a Thiazole Moiety. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401542
BibTeX
@article{Ma2024,
author = {Ma, Xin-Yu and Li, Ming-Yue and Jin, Kai-Han and Han, Zhen-Yuan and Gao, Yuan-Liang and Jin, Xue-Jun and Zhao, Yu-Qing and Piao, Hu-Ri},
title = {Design, Synthesis, and Hypoxia‐Inducible Factor‐1α Inhibitory Activity Evaluation of Panaxadiol Derivatives Containing a Thiazole Moiety},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202401542}
}
EUVIMED